|Slideshows|August 10, 2020
13 Psychiatric Drugs With Novel Mechanisms: A Timeline
Author(s)John J. Miller, MD
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Advertisement
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
2
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
3
Monoamines: A Full House
4
ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings
5